Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT06121934
Eligibility Criteria:
Inclusion Criteria:
* Patients who are confirmed dengue fever by NS1 dengue Ag or anti dengue Ab IgM positive
Exclusion Criteria:
* Children (\<18 years)
* Currently pregnant or lactating
* Patients on steroids, any immunosuppressant
* Patients who received platelet transfusion during the same admission
* Patient with other known causes of thrombocytopenia, including leukemia, ITP
* Patients with alanine aminotransferase (ALT) levels \>150 U/L
* Patient with serum creatine \>1.4 mg/dl
* S. creatine kinase (CK) \>1000 U/L
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06121934
Study Brief:
Protocol Section:
NCT06121934